Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

N

NRXP

NRX Pharmaceuticals Inc

3.61

Jul 28 • 5:15 AM ET -0.02 (-0.60%)

Healthcare Biotechnology USA Micro NASD

Peers: AARD AGEN CNTB GALT IMUX KZIA NTHI SPRO VRCA KALA

| Held by: VTI PSIL VXF IWC

Scroll to Statements

Index	-
Market Cap	151.33M
Enterprise Value	145.55M
Income	-24.54M
Sales	2.29M
Book/sh	-0.41
Cash/sh	0.16
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	29
IPO	Dec 04, 2017

P/E	-
Forward P/E	10.24
PEG	-
P/S	66.08
P/B	-
P/C	22.55
P/FCF	-
EV/EBITDA	-
EV/Sales	63.56
Quick Ratio	0.29
Current Ratio	0.29
Debt/Eq	-
LT Debt/Eq	-
Option/Short	Yes / Yes

EPS (ttm)	-1.28
EPS next Y	0.35
EPS next Q	-0.11
EPS this Y	72.07%
EPS next Y	194.21%
EPS next 5Y	-
EPS past 3/5Y	39.52% 38.42%
Sales past 3/5Y	- -
EPS Y/Y TTM	36.33%
Sales Y/Y TTM	-
EPS Q/Q	86.84%
Sales Q/Q	-
Earnings	May 15 BMO
EPS/Sales Surpr.	-119.14% -94.50%

Insider Own	11.62%
Insider Trans	0.00%
Inst Own	15.05%
Inst Trans	-1.31%
ROA	-251.79%
ROE	-
ROIC	-
Gross Margin	37.11%
Oper. Margin	-749.67%
Profit Margin	-1070.26%
SMA20	-11.80%
SMA50	-8.72%
SMA200	29.58%
Trades

Shs Outstand	41.94M
Shs Float	37.07M
Short Float	16.72%
Short Ratio	5.26
Short Interest	6.20M
52W High	5.05 -28.62%
52W Low	1.62 122.72%
Volatility	9.72% 7.90%
ATR (14)	0.31
RSI (14)	40.17
Beta	2.17
Rel Volume	0.03
Avg Volume	1.18M
Volume	1,742

Perf Week	-19.10%
Perf Month	-3.27%
Perf Quarter	19.08%
Perf Half Y	70.19%
Perf YTD	33.14%
Perf Year	23.14%
Perf 3Y	1.38%
Perf 5Y	-97.78%
Perf 10Y	-
Recom	1.00
Target Price	42.00
Prev Close	3.63
Price	3.61
Change	-0.60%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)